Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $334.38M | $287.07M | 65.59% | -$47.31M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $73.75M | $58.74M | 13.42% | -$15.01M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 7,464,572 | 7,464,572 | 0 | $60.61M | $46.80M | 10.69% | -$13.81M |
| Rapt Therapeutics Inc | 22,352,000 | 22,352,000 | 0 | $35.32M | $27.27M | 6.23% | -$8.05M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $24.99M | $17.81M | 4.07% | -$7.17M |